Summary
Several drugs with a catechol moiety were studied for their potency to inhibit tyrosine hydroxylase (TH) from PC-12 cells in vitro. When the natural compounds tested were compared, dopamine, norepinephrine and 2(3,4-dihydroxyphenyl)-ethanol (DOPET) were most effective (IC50 between 1.4 and 3.6 μM with 0.5 μM 6(R,S)-l-erythro-5,6,7,8-tetrahydrobiopterin as cofactor). 3,4-Dihydroxyphenylalanine (DOPA; IC50: 35 μM) and 3,4-dihydroxyphenylacetic acid (DOPAC; IC50: 180 μM were less potent inhibitors. Among the synthetic drugs possessing catechol moiety, isoproterenol, (±)-2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (6,7-ADTN) and (±)-2-dimethylamino-6,7-dihydroxy-tetrahydronaphthalene (TL-99) had the same inhibitory effects as the natural catecholamines (IC50 between 1.6 and 3.9 μM), whereas the apomorphine derivatives and 2,3,4,5-tetrahydro-1-phenyl-1 H-3-benzazepine-7,8-diol (SKF 38393) were even more potent (IC50: 0.5–0.8 μM).
These results demonstrate that natural catechols and certain drugs (e.g. 6,7-ADTN, TL-99, SKF 38393) are more effective direct blockers of tyrosine hydroxylase than generally assumed provided appropriate assay conditions are used. In the case of dopamine and norepinephrine, these findings suggest a reevaluation of their role for feedback control of tyrosine hydroxylase in vivo.
Similar content being viewed by others
Abbreviations
- 6,7-ADTN:
-
(±)-2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene
- BH4 :
-
6(R,S)-l-erythro-5,6,7,8-tetrahydrobiopterin
- DMPH4 :
-
2-amino-4-hydroxy-6,7-dimethyl-tetrahydropteridine
- DOPA:
-
3,4-dihydroxyphenylalanine
- DOPAC:
-
3,4-dihydroxyphenylacetic acid
- DOPET:
-
2(3,4-dihydroxyphenyl)ethanol
- ELCD:
-
electrochemical detection
- 6-MPH4 :
-
6-methyl-5,6,7,8-tetrahydropteridine
- NSD 1015:
-
3-hydroxy-benzyl-hydrazine
- SKF 38393:
-
2,3,4,5-tetrahydro-1-phenyl-1 H-3-benzazepine-7,8-diol
- TH:
-
tyrosine hydroxylase
- TL-99:
-
(±)-2-dimethylamino-6,7-dihydroxy-tetrahydronaphthalene
References
Acheson AL, Kapatos G, Zigmond MJ (1981) The effects of phosphorylating conditions on tyrosine hydroxylase activity are influenced by assay conditions and brain region. Life Sci 28:1407–1420
Ames MM, Lerner P, Lovenberg W (1978) Tyrosine hydroxylase: Activation by protein phosphorylation and end product inhibition. J Biol Chem 253:27–31
Bräutigam M, Dreesen R, Herken H (1982) DOPA-release from mouse neuroblastoma clone N1E-115 into the culture medium — a test for tyrosine hydroxylase activity. Naunyn-Schmiedeberg's Arch Pharmacol 320:85–89
Bräutigam M, Dreesen R, Herken H (1984) Tetrahydrobiopterin and total biopterin content of neuroblastoma (N1E-115, N2A) and pheochromocytoma (PC-12) clones and the dependence of catecholamine synthesis on tetrahydrobiopterin concentration in PC-12 cells. J Neurochem 42:390–396
Bräutigam M, Kittner B, Laschinski G, Herken H (1985) Effect of apomorphine, d-methylparatyrosine, haloperidol and reserpine on DOPA production in clonal cells lines (PC-12 and N1E-115). Biochem Pharmacol 34:941–947
Bullard WP, Guthrie PB, Russo PV, Mandell AJ (1978) Regional and subcellular distribution and some factors in the regulation of reduced pterins in rat brain. J Pharmacol Exp Ther 206: 4–20
Carlsson A, Kehr W, Lindqvist M (1976) The role of intraneuronal amine levels in the feedback control of dopamine, noradrenaline and 5-hydroxytryptamine synthesis in rat brain. J Neural Transm 39:1–19
Fisher DB, Kaufman S (1972) The inhibition of phenylalanine and tyrosine hydroxylases by high oxygen levels. J Neurochem 19:1359–1365
Foreman MM, Porter, JC (1980) Effects of catechol estrogens and catecholamines on hypothalamic and corpus striatal tyrosine hydroxylase activity. J Neurochem 34:1175–1183
Fowler CJ, Thorell G, Andersson M, Magnusson O (1985) Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function? Naunyn-Schmiedeberg's Arch Pharmacol 331:12–19
Gál EM, Sherman AD (1976) Biopterin II. Evidence for cerebral synthesis of 7,8-dihydrobiopterin in vivo and in vitro. Neurochem Res 1:627–639
Goodale DB, Rusterholz DB, Long JP, Flynn JR, Walsh B, Cannon JG, Lee T (1980) Neurochemical and behavioural evidence for a selective presynaptic dopamine receptor agonist. Science 210:1141–1143
Hegstrand LR, Simon JR, Roth RH (1979) Tyrosine hydroxylase: Examination of conditions influencing activity in pheochromocytoma, adrenal medulla and striatum. Biochem Pharmacol 28:519–523
Ikeda M, Fahien LA, Udenfriend S (1966) A kinetic study of bovine adrenal hydroxylase. J Biol Chem 241:4452–4456
Kapatos G, Zignond MJ (1982) Influence of calcium on dopamine synthesis and tyrosine hydroxylase activity in rat striatum. J Neurochem. 39:327–335
Kato T, Oka K, Nagatsu T, Sugimoto T, Matsuura S (1980) Effects of structures of tetrahydrobiopterin cofactors on tyrosine hydroxylase. Biochim Biophys Acta 612:226–232
Kuczenski R (1973) Soluble, membrane-bound, and detergent-solubilized rat striatal tyrosine hydroxylase. J Biol Chem 248:5074–5080
Kuczenski R (1981) Monovalent cations and striatal tyrosine hydroxylase. J Neurochem 37:681–686
Laschinski G, Kittner B, Bräutigam M (1984) Inhibition of striatal tyrosine hydroxylase by low concentrations of apomorphine. Naunyn-Schmiedeberg's Arch Pharmacol 327:114–118
Lazar MA, Barchas JD (1982) The regulation of tyrosine hydroxylase activity by phosphorylation. Adv Biosci 37:285–290
Levine RA, Miller LP, Lovenberg W (1981) Tetrahydrobiopterin in striatum: Localization in dopamine nerve terminals and role in catecholamine synthesis. Science 214:919–920
Levitt M, Spector S, Sjoerdsma A, Udenfriend S (1965) Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guinea-pig heart. J Pharmacol Exp Ther 148:1–8
Levitt M, Gibb JW, Daly JW, Lipton M, Udenfriend S (1967) A new class of tyrosine hydroxylase inhibitors and a simple assay of inhibition in vivo. Biochem Pharmacol 16:1313–1321
Lloyd, T, Ebersole BJ (1980) Feedback inhibition of tyrosine hydroxylase from five regions of rat brain by 2-hydroxyestradiol and dihydroxyphenylalanine. J Neurochem 31:726–731
Lowry OH, Rosebrough HJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Markey KA, Kondo S, Shenkman L, Goldstein M (1980) Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line. Mol Pharmacol 17:79–83
Martin GE, Haubrich DR, Williams M (1981) Pharmacological profiles of the putative dopamine autoreceptor agonist 3-PPP and TL-99. Eur J Pharmacol 76:15–23
Nagatsu T, Levitt M, Udenfriend S (1964) Tyrosine hydroxylase: The initial step in norepinephrine biosynthesis. J Biol Chem 239:2910–2917
Nagatsu T, Oka K, Kato T (1979) High sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. J Chromat 163:247–252
Oka K, Kato T, Sugimoto T, Matsuura S, Nagatsu T (1981) Kinetic properties of tyrosine hydroxylase with natural tetrahydrobiopterin as cofactor. Biochim Biophys Acta 661:45–53
Perlman RL, Sheard EB (1982) Estimation of the cytoplasmic catecholamine concentrations in pheochromocytoma cells. Biochim Biophys Acta 719:334–340
Petrack B, Sheppy F, Fetzer V (1968) Studies on tyrosine hydroxylase from bovine adrenal medulla. J Biol Chem 243:743–748
Pollock RJ, Kapatos G, Kaufman S (1981) Effect of cyclic AMP-dependent protein phosphorylation conditions on the pH-dependent activity of tyrosine hydroxylase from beef and rat strita. J Neurochem 37:855–860
Seeman P (1981) Brain dopamine receptors. Pharmacol Rev 32:229–313
Shen R, Smith RV, Davis PJ, Creed WA (1984) Inhibition of dihydropteridine reductase from human liver and rat striatal synaptosomes by apomorphine and its analogues. J Biol Chem 259:8994–9000
Simon JR, Hegstrand LR, Roth RH (1978) Regulation of tyrosine hydroxylase from human pheochromocytoma, bovine adrenal and rat striatum. Life Sci 22:421–428
Udenfriend S, Zaltzman-Nirenberg P, Nagatsu T (1965) Inhibitors of purified beef adrenal tyrosine hydroxylase. Biochem Pharmacol 14:837–845
Waggoner WG, McDermed J, Leighton HJ (1980) Presynaptic regulation of tyrosine hydroxylase activity in rat striatal synaptosomes by dopamine analogs. Mol Pharmacol 18:91–99
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Laschinski, G., Kittner, B. & Bräutigam, M. Direct inhibition of tyrosine hydroxylase from PC-12 cells by catechol derivatives. Naunyn-Schmiedeberg's Arch. Pharmacol. 332, 346–350 (1986). https://doi.org/10.1007/BF00500085
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00500085